G&G Capital

G&G Capital is a China-based healthcare-focused financial advisory firm headquartered in Beijing. The firm positions itself as a specialist advisor to medical, biotech, pharmaceutical, and medtech companies, providing services in financing, mergers and acquisitions, global business development, investor relations, and strategic industry analysis. Publicly available descriptions indicate that it helps connect healthcare companies with Chinese investors and supports cross-border business development. It appears to operate as a service provider to life sciences companies rather than as a therapeutic product developer, so it does not have a drug pipeline in the conventional biotech sense.